enGene Therapeutics Inc.
Biological Products, (No Diagnostic Substances) | SIC: 2836Phone: (514) 332-4888
State of Inc.: Z4
- Nasdaq:ENGN
- Nasdaq:ENGNW
Form: EFFECT
Filing Date: 02 Mar 2026Report Date:
Accepted: 02 Mar 2026 10:15 p.m.
Accession Number: 9999999995-26-000700
File Number: 333-293597
Film Number: 26710922
Items: ,,